MECHANICAL BACK PAINNCT07596953
Efficacy of TECAR Therapy on Patient With Mechanical Neck Pain
A study testing TECAR and Conventional in people with MECHANICAL BACK PAIN, run by Batterjee Medical College at 1 site in Saudi Arabia.
Trial summary
The goal of this clinical trial is to evaluate the effectiveness of TECAR therapy in improving pain intensity, cervical range of motion, and functional disability in individuals with mechanical neck pain. Read more about this study
- Who is it for?
- Ages 20 to 40 years
- Conditions the study is for
- MECHANICAL BACK PAIN
- What is being tested?
- TECAR and Conventional
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteSaudi Arabia
- Study dates
- 9 Jul 2026to 25 Oct 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 40 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Presence of neck pain for at least 3 months
- Limited cervical range of motion associated with neck pain
- Ability to understand and follow study instructions Willingness to participate and sign the informed consent form
Who cannot join
- History of cervical spine surgery or fracture
- Cervical radiculopathy or other neurological disorders
- Presence of inflammatory, rheumatic, or systemic diseases affecting the cervical spine
- Severe cervical disc prolapse or spinal instability Current participation in another treatment program for neck pain Pregnancy Presence of pacemakers, metal implants, or contraindications to TECAR therapy Skin disorders or open wounds in the treatment area
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Saudi Arabia1 site, 1 recruiting
- Recruiting
Saudi German Hospital
Jeddah, Al Zahraa, 23623
About this study
Official title: Influence of TECAR Therapy on Cervical Mobility and Functional Disability in Patients With Mechanical Neck Pain: Randomized Control Study
The goal of this clinical trial is to evaluate the effectiveness of TECAR therapy in improving pain intensity, cervical range of motion, and functional disability in individuals with mechanical neck pain. It will also assess whether TECAR therapy provides additional clinical benefits compared with conventional physical therapy treatment. The main questions it aims to answer are:
- Does TECAR therapy reduce pain intensity in patients with mechanical neck pain?
- Does TECAR therapy improve cervical range of motion (CROM)?
- Does TECAR therapy reduce functional disability as measured by the Neck Disability Index (NDI)? Researchers will compare participants receiving TECAR therapy combined with conventional physical therapy to participants receiving conventional physical therapy alone to determine the effectiveness of TECAR therapy in managing mechanical neck pain.
Read more
Participants will:
- Attend scheduled treatment sessions during the study period
- Receive either TECAR therapy with conventional physical therapy or conventional physical therapy alone
- Undergo assessment of pain intensity, cervical range of motion, and neck disability before and after treatment
Read the detailed description
Mechanical neck pain is one of the most common musculoskeletal disorders and is frequently associated with pain, restricted cervical mobility, and reduced functional performance, which may negatively affect daily activities and quality of life. Conventional physical therapy interventions are commonly used to manage mechanical neck pain; however, interest has recently increased in the use of TECAR therapy as a non-invasive modality that may enhance tissue healing, improve circulation, reduce pain, and restore function.
This single-blind randomized controlled trial aims to investigate the clinical effectiveness of TECAR therapy in individuals with mechanical neck pain. Participants who meet the eligibility criteria will be randomly assigned to either an experimental group receiving TECAR therapy in combination with conventional physical therapy or a control group receiving conventional physical therapy alone.
Outcome measures will be assessed before and after the intervention period and will include pain intensity, cervical range of motion (CROM), and functional disability using the Neck Disability Index (NDI). The study seeks to determine whether adding TECAR therapy to a conventional rehabilitation program provides superior improvements in pain reduction, cervical mobility, and functional outcomes in patients with mechanical neck pain.
- Conditions
- MECHANICAL BACK PAIN
- Being tested
- TECAR, Conventional
- Keywords
- TECAR Therapy, Mechanical Neck Pain, Functional Disability
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TECARDevice
Participants in the TECAR group received TECAR therapy in capacitive and resistive modes targeting superficial and deep tissues of the affected area. Each session lasted 20-30 minutes, with intensity adjusted to produce a comfortable thermal effect without pain. TECAR therapy was applied three times/week for 12 weeks, alongside a standardized exercise program identical to the control group.
ConventionalOther
Participants in the control group received a standardized therapeutic exercise program. The program included stretching, strengthening, and functional exercises targeting the affected region. Each session lasted 20-30 minutes and was performed three times/week for 12 weeks.
| Study group | Role | What they receive |
|---|---|---|
| TECAR Therapy Group for Mechanical Neck Pain | Experimental | Participants will receive TECAR therapy combined with a conventional physical therapy program for mechanical neck pain. Receives: Device: TECAR; Other: Conventional |
| Conventional Physical Therapy Group for Mechanical Neck Pain | Active comparator | Participants will receive a conventional physical therapy program only. Receives: Other: Conventional |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain Intensity
Pain intensity was measured using the Visual Analog Scale (VAS) to assess changes in neck pain intensity throughout the study period. The VAS is a self-reported pain assessment tool consisting of a 10-cm horizontal line, with scores ranging from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain." Higher scores represent greater pain intensity and therefore a worse outcome.
Measured: Assessments will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Secondary outcomes (2)
Cervical Range of Motion (CROM)
Measured using a Cervical Range of Motion device to evaluate changes in cervical flexion, extension, lateral flexion, and rotation.
Measured: Baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Functional Disability
Functional disability was measured using the Neck Disability Index (NDI) to assess changes in functional limitations associated with mechanical neck pain. The NDI is a self-administered questionnaire consisting of 10 items related to daily activities and pain. Each item is scored from 0 to 5, with a total score ranging from 0 to 50, where 0 indicates no disability and 50 indicates complete disability. Higher scores represent greater functional disability and therefore a worse outcome.
Measured: Assessment will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 May 2026
- Study start9 Jul 2026
- Primary completion30 Sep 2026 (estimated)
- Study completion25 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MECHANICAL BACK PAINStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Batterjee Medical College
- Sponsor type
- University, hospital or other
- Collaborators
- Saudi German Hospital
- Responsible party
- Principal investigator, Mohamed A. Abdel Ghafar, Batterjee Medical College
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07596953
- Sponsor's protocol ID
- BMCSGHTECAR
- Status last verified
- Sep 2026
- First submitted
- 13 May 2026
- Last updated
- 10 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Influence of TECAR Therapy on Cervical Mobility and Functional Disability in Patients With Mechanical Neck Pain: Randomized Control Study
- ClinicalTrials.gov ID
- NCT07596953
- Acronym / sponsor ID
- BMCSGHTECAR
- Conditions
- MECHANICAL BACK PAIN
- Keywords
- TECAR Therapy, Mechanical Neck Pain, Functional Disability
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Batterjee Medical CollegeUniversity, hospital or other
- Collaborators
- Saudi German Hospital
- Study start
- 9 Jul 2026 (actual)
- Primary completion
- 30 Sep 2026 (estimated)
- Study completion
- 25 Oct 2026 (estimated)
- First posted
- 19 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to evaluate the effectiveness of TECAR therapy in improving pain intensity, cervical range of motion, and functional disability in individuals with mechanical neck pain. It will also assess whether TECAR therapy provides additional clinical benefits compared with conventional physical therapy treatment. The main questions it aims to answer are:
- Does TECAR therapy reduce pain intensity in patients with mechanical neck pain?
- Does TECAR therapy improve cervical range of motion (CROM)?
- Does TECAR therapy reduce functional disability as measured by the Neck Disability Index (NDI)? Researchers will compare participants receiving TECAR therapy combined with conventional physical therapy to participants receiving conventional physical therapy alone to determine the effectiveness of TECAR therapy in managing mechanical neck pain.
Participants will:
- Attend scheduled treatment sessions during the study period
- Receive either TECAR therapy with conventional physical therapy or conventional physical therapy alone
- Undergo assessment of pain intensity, cervical range of motion, and neck disability before and after treatment
Detailed description
Mechanical neck pain is one of the most common musculoskeletal disorders and is frequently associated with pain, restricted cervical mobility, and reduced functional performance, which may negatively affect daily activities and quality of life. Conventional physical therapy interventions are commonly used to manage mechanical neck pain; however, interest has recently increased in the use of TECAR therapy as a non-invasive modality that may enhance tissue healing, improve circulation, reduce pain, and restore function.
This single-blind randomized controlled trial aims to investigate the clinical effectiveness of TECAR therapy in individuals with mechanical neck pain. Participants who meet the eligibility criteria will be randomly assigned to either an experimental group receiving TECAR therapy in combination with conventional physical therapy or a control group receiving conventional physical therapy alone.
Outcome measures will be assessed before and after the intervention period and will include pain intensity, cervical range of motion (CROM), and functional disability using the Neck Disability Index (NDI). The study seeks to determine whether adding TECAR therapy to a conventional rehabilitation program provides superior improvements in pain reduction, cervical mobility, and functional outcomes in patients with mechanical neck pain.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| TECAR Therapy Group for Mechanical Neck Pain | Experimental | Device: TECAR, Other: ConventionalParticipants will receive TECAR therapy combined with a conventional physical therapy program for mechanical neck pain. |
| Conventional Physical Therapy Group for Mechanical Neck Pain | Active comparator | Other: ConventionalParticipants will receive a conventional physical therapy program only. |
Who may qualify
- Ages
- 20 to 40 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Presence of neck pain for at least 3 months
- Limited cervical range of motion associated with neck pain
- Ability to understand and follow study instructions Willingness to participate and sign the informed consent form
Key exclusion criteria (4 listed)
- History of cervical spine surgery or fracture
- Cervical radiculopathy or other neurological disorders
- Presence of inflammatory, rheumatic, or systemic diseases affecting the cervical spine
- Severe cervical disc prolapse or spinal instability Current participation in another treatment program for neck pain Pregnancy Presence of pacemakers, metal implants, or contraindications to TECAR therapy Skin disorders or open wounds in the treatment area
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TECARParticipants in the TECAR group received TECAR therapy in capacitive and resistive modes targeting superficial and deep tissues of the affected area. Each session lasted 20-30 minutes, with intensity adjusted to produce a comfortable thermal effect without pain. TECAR therapy was applied three times/week for 12 weeks, alongside a standardized exercise program identical to the control group. | Device | TECAR Therapy Group for Mechanical Neck Pain |
| ConventionalParticipants in the control group received a standardized therapeutic exercise program. The program included stretching, strengthening, and functional exercises targeting the affected region. Each session lasted 20-30 minutes and was performed three times/week for 12 weeks. | Other | Conventional Physical Therapy Group for Mechanical Neck Pain, TECAR Therapy Group for Mechanical Neck Pain |
Primary outcome
Pain Intensity
Time frame: Assessments will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Pain intensity was measured using the Visual Analog Scale (VAS) to assess changes in neck pain intensity throughout the study period. The VAS is a self-reported pain assessment tool consisting of a 10-cm horizontal line, with scores ranging from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain." Higher scores represent greater pain intensity and therefore a worse outcome.
2 secondary outcomes
Cervical Range of Motion (CROM)
Time frame: Baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Functional Disability
Time frame: Assessment will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for MECHANICAL BACK PAIN
Not yet recruiting
Effect of Lumbar Stabilization Exercises With and Without YTWL (Scapular Stabilization Exercises) on Reducing Chronic Low Back Pain and Related Disability. A Randomized Clinical Trial,
Chronic Non Specific Mechanical Low Back Pain
Not yet recruiting
Effect of Dry Needling Plus Vibration on Myofascial Trigger Points in Individuals With Nonspecific Low Back Pain
Low Back Pain, Dry Needling
Recruiting
Fusion or Not - a Study on Low Back Pain
Low Back Pain, Mechanical, Degenerative Disc Disease Lumbar
Recruiting
Effects of Post-Isometric Relaxation and Myofascial Release on Low Back Pain With Lower Cross Syndrome
Low Back Pain, Mechanical, Lower Cross Syndrome
RecruitingPhase 1
Adia Med of Winter Park LLC Lower Back Pain Research Study
Chronic Mechanical Lower Back Pain, Lower Back Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing TECAR and Conventional in people with MECHANICAL BACK PAIN, run by Batterjee Medical College at 1 site in Saudi Arabia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 10 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mohamed A Abdel Ghafar, Ph.D. (00966531513909, Pt12.jed@bmc.edu.sa), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain Intensity (time frame: Assessments will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2026.